^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Del(7q) Deletion FISH Probe Kit

Company:
Sysmex Corp
Type:
FDA Approved
Related tests:

Details

Evidence
News
The Del(7q) Deletion FISH Probe Kit is a fluorescence in situ hybridization (FISH) Test used to detect deletions within the long arm of chromosome 7 at locations 7q22 and 7q31.2 in fixed bone marrow specimens from patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The test is indicated for characterization of patient specimens consistent with World Health Organization (WHO) guidelines for Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition) and in conjunction with other clinicopathological criteria. The assay results are intended to be interpreted by a qualified pathologist or cytogeneticist. The test is not intended for use as a stand-alone diagnostic, disease screening, or as a companion diagnostic.
Cancer:
Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Method:
Fluorescence in situ hybridization (FISH)
Approvals
Date
Cancer
Gene
Drug
By
12/21/18
FDA